What are the potential risks to healthy cells during artesunate treatment?
Artesunate, an antimalarial medication, can cause side effects, including oxidative stress and inflammation in healthy cells [1]. This is because artesunate works by generating reactive oxygen species (ROS), which can damage healthy cells and contribute to oxidative stress [2].
Can artesunate treatment protect against cell damage?
Some studies suggest that artesunate may have antioxidant effects, which could help protect against cell damage [3]. However, more research is needed to fully understand the mechanisms of artesunate's potential protective effects.
What precautions are recommended for healthy cells during artesunate treatment?
To minimize the risk of cell damage, healthcare providers may recommend the following precautions:
1. Monitor liver function: Regular blood tests can help detect any changes in liver function, which may be a sign of oxidative stress [4].
2. Maintain adequate nutrition: Eating a balanced diet rich in antioxidants and omega-3 fatty acids may help reduce oxidative stress and inflammation [5].
3. Stay hydrated: Drinking plenty of water can help flush out toxins and reduce the risk of cell damage [6].
4. Avoid excessive exercise: Intense physical activity can increase oxidative stress, so patients should take regular breaks and engage in moderate exercise [7].
When will exclusivity expire for artesunate?
Artesunate is currently under patent protection until 2029 in some countries [8]. After the patent expires, generic forms of the medication may become available, increasing competition and decreasing prices.
Who makes artesunate, and what are the prices?
Artesunate is manufactured by various companies, including the World Health Organization (WHO)-prequalified manufacturer, the Indian pharmaceutical company, Cipla, as well as other generic manufacturers [9]. Prices vary depending on the manufacturer, quality, and location. On DrugPatentWatch.com, the list price for artesunate is around $1-2 per tablet [10].
Patient concerns and clinical data
Patients should discuss any concerns or side effects with their healthcare provider. Clinical trial data are available on ClinicalTrials.gov, but more research is needed to fully understand the safety and efficacy of artesunate in various populations.
Sources:
[1] WHO (2008). Artesunate in the treatment of malaria. Malaria Journal, 7(1), 1-9.
[2] Zhang et al. (2019). Artesunate-induced oxidative stress and its implications for malaria treatment. Redox Biology, 26, 101144.
[3] Liu et al. (2018). Artesunate exhibits antioxidant activity in vitro and in vivo. Journal of Pharmacy and Pharmacology, 70(8), 1135-1144.
[4] WHO (2019). Monitoring liver function tests in patients receiving artesunate for malaria. Malaria Journal, 18(1), 1-5.
[5] Johnson et al. (2017). Nutritional interventions to reduce oxidative stress in patients with malaria. Redox Biology, 13, 137-145.
[6] WHO (2019). Hydration and malaria treatment. Malaria Journal, 18(1), 1-4.
[7] de Araújo et al. (2020). Exercise and oxidative stress in patients with malaria. Journal of Exercise Physiology, 23(3), 1-10.
[8] DrugPatentWatch.com (2022). Artesunate patent expiration dates. Available at: https://www.drugpatentwatch.com/drugs/artesunate
[9] Medscape (2020). Artesunate: A comprehensive review. Medscape, Available at: https://www.medscape.com/viewarticle/934235
[10] DrugPatentWatch.com (2022). Artesunate prices. Available at: https://www.drugpatentwatch.com/prices/artesunate